RIPK3 and acute myeloid leukemia: Similarly, another study also shows that knockout of RIPK3 in mice has markedly enhanced leukemogenesis by promoting the accumulation of leukemia-initiating cells and further connection between RIPK3 suppression and cell death blockage, which is also validated in primary AML patient cohorts [33].